DrugPatentWatch Database Preview
Kvk Tech Company Profile
Email this page to a colleague
What is the competitive landscape for KVK TECH, and when can generic versions of KVK TECH drugs launch?
KVK TECH has thirteen approved drugs.
There are five US patents protecting KVK TECH drugs.
There are thirty-five patent family members on KVK TECH drugs in twenty countries and fifty-six supplementary protection certificates in seven countries.
Summary for Kvk Tech
| International Patents: | 35 |
| US Patents: | 5 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 13 |
Drugs and US Patents for Kvk Tech
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kvk Tech | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | TABLET;ORAL | 078962-001 | Jun 27, 2008 | AB | RX | No | No | ⤷ Free Forever Trial | ⤷ Free Forever Trial | ||||
| Kvk Tech | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 040712-003 | Jul 31, 2006 | AB | RX | No | No | ⤷ Free Forever Trial | ⤷ Free Forever Trial | ||||
| Kvk Tech | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | TABLET;ORAL | 078962-002 | Jun 27, 2008 | AB | RX | No | No | ⤷ Free Forever Trial | ⤷ Free Forever Trial | ||||
| Kvk Tech Inc | APADAZ | acetaminophen; benzhydrocodone hydrochloride | TABLET;ORAL | 208653-002 | Jan 4, 2019 | RX | Yes | No | 8,748,413 | ⤷ Free Forever Trial | Y | Y | ⤷ Free Forever Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kvk Tech Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Chile | 2011003347 | ⤷ Free Forever Trial |
| Israel | 217096 | ⤷ Free Forever Trial |
| Ukraine | 102916 | ⤷ Free Forever Trial |
| Russian Federation | 2012103476 | ⤷ Free Forever Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kvk Tech Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1856135 | 2020/017 | Ireland | ⤷ Free Forever Trial | PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REGISTRATION NO/DATE: EU/1/19/1405 20200113 |
| 0268956 | SPC/GB98/040 | United Kingdom | ⤷ Free Forever Trial | PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508 |
| 0480717 | 98C0022 | France | ⤷ Free Forever Trial | PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825 |
| 2822954 | 1890030-8 | Sweden | ⤷ Free Forever Trial | PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM; REG. NO/DATE: EU/1/18/1289 20180625 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
